The 24-month project will focus on Charco’s CUE1 – a wearable device to alleviate the symptoms of Parkinson’s.
The scope of the project includes testing the CUE1’s feasibility, assessing its tolerability and effect on clinical outcome measures, assessing optimal stimulation settings and positioning for the CUE1, and drafting a design for a formal clinical trial.